| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/05/2007 | US7227010 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 06/05/2007 | US7227007 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents |
| 06/05/2007 | US7227005 Vascular endothelial growth factor 2 |
| 06/05/2007 | US7227002 Human antibodies that bind human 17-A1/EpCAM tumor antigen |
| 06/05/2007 | US7227000 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 06/05/2007 | US7226995 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 06/05/2007 | US7226912 Hepatitis C virus non-structural NS3/4A fusion gene |
| 06/05/2007 | US7226911 Hair keratin-associated proteins |
| 06/05/2007 | US7226909 Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
| 06/05/2007 | US7226775 Treating the solution with an ionic surfactant to dissociate the endotoxin from the amphiphilic solution; filtering the solution through a molecular weight cut-off filter to retain the amphiphilic drug or vaccine |
| 06/05/2007 | US7226774 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/05/2007 | US7226749 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 06/05/2007 | US7226741 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 06/05/2007 | US7226605 Botulinum toxin in the treatment or prevention of acne |
| 06/05/2007 | US7226604 Chemically inactivated EHV-1 KyA virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer |
| 06/05/2007 | US7226603 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/05/2007 | US7226602 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 06/05/2007 | US7226601 binds to both the T cell receptor and an MHC class II antigen; superantigen peptide and affinity counterpart are covalently linked; conjugates have the ability to activate and direct T-lymphocytes |
| 06/05/2007 | US7226599 Diagnostic reagent for hepatitis C virus infection |
| 06/05/2007 | US7226598 Soluble trimeric coiled-coil peptide for preventing infection and replication of lymphadenopathy associated virus |
| 06/05/2007 | US7226597 Vaccine for humans, animals; forming antibodies; genetic engineering; mutant polypeptide |
| 06/05/2007 | US7226596 Metalloenzymes; antiproliferative agents; anticarcinogenic agents; cancer diagnosis; antisense agents; complementary determining regions |
| 06/05/2007 | US7226595 Conjugated antigen for use as tool in the treatment of cancer |
| 06/05/2007 | US7226594 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 06/05/2007 | US7226593 Methods of treating cachexia with chimeric anti-TNF antibodies |
| 06/05/2007 | US7226592 different epitopes are located within the binding domain of the natural ligand(s) of said receptor; first and second antigen-binding site binds to a different epitope on the same EGFR molecule |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 06/05/2007 | US7226590 Antimicrobial composition |
| 06/05/2007 | US7226589 Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor |
| 06/05/2007 | US7226588 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 06/05/2007 | US7226429 passing HIV infected blood or plasma through a porous hollow fiber membrane of immobilized lectin molecules; virions and fragments which contain high mannose glycoproteins to bind to the lectins |
| 06/05/2007 | CA2273823C Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/05/2007 | CA2143442C Dorsal tissue affecting factor and compositions |
| 06/05/2007 | CA2095235C A diagnostic assay for lyme disease |
| 06/02/2007 | CA2632245A1 Novel plant virus particles and methods of inactivation thereof |
| 05/31/2007 | WO2007062371A2 Live vector vaccine and uses thereof |
| 05/31/2007 | WO2007062088A1 Antibody treatment of alzheimer's and related diseases |
| 05/31/2007 | WO2007062040A1 Immunoglobulin fusion protein formulations |
| 05/31/2007 | WO2007061969A2 Vaccines against influenza a and influenza b |
| 05/31/2007 | WO2007061936A2 Clearance of abnormal iga1 in iga1 deposition diseases |
| 05/31/2007 | WO2007061886A2 Compositions and methods for ameliorating toxins and virulence factors |
| 05/31/2007 | WO2007061874A2 Methods and compositions for use in treating cancer |
| 05/31/2007 | WO2007061781A1 Coatable compositions, coatings derived therefrom and microarrays having such coatings |
| 05/31/2007 | WO2007061759A1 Delayed expression vectors |
| 05/31/2007 | WO2007061679A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 05/31/2007 | WO2007061657A2 Interleukin-10 compositions for the treatment of adenocarcinomas |
| 05/31/2007 | WO2007061292A1 Uses of the fcrn receptor |
| 05/31/2007 | WO2007061281A2 Prevention and treatment of porcine reproductive and respiratory syndrome (prrs) |
| 05/31/2007 | WO2007061029A1 Therapeutic agent for prostate cancer |
| 05/31/2007 | WO2007060918A1 Novel memory ctl induction potentiator |
| 05/31/2007 | WO2007060864A1 Antibody-producing precursor b cell whose growth and differentiation can be controlled |
| 05/31/2007 | WO2007060725A1 Recombinant polyvalent vaccine |
| 05/31/2007 | WO2007060425A1 Thrombospondin domain-containing cell surface recognition molecules |
| 05/31/2007 | WO2007060423A1 Signal anchored protein |
| 05/31/2007 | WO2007060411A1 Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r |
| 05/31/2007 | WO2007059997A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/31/2007 | WO2007059979A2 Allergy treatment by epicutaneous allergen administration |
| 05/31/2007 | WO2007059625A1 Bacterial antigens and uses thereof |
| 05/31/2007 | WO2007042524A3 Treating diabetes using inhibitors of il-1 |
| 05/31/2007 | WO2007042169A3 Matrix metalloproteinase 11 vaccine |
| 05/31/2007 | WO2007037560A9 Therapeutic or diagnostic application of sgk2 gene |
| 05/31/2007 | WO2007037555A9 Therapeutic or diagnostic application of dusp15 gene |
| 05/31/2007 | WO2007037550A9 Therapeutic or diagnostic application of tsta3 gene |
| 05/31/2007 | WO2007037538A9 Therapeutic or diagnostic application of spo11 gene |
| 05/31/2007 | WO2007037533A9 Therapeutic or diagnostic application of ppp1r3d gene |
| 05/31/2007 | WO2007037532A9 Therapeutic or diagnostic application of srms gene |
| 05/31/2007 | WO2007025276A3 Use of hiv envelope/ cd4 complexes as immunogenic complexes for the generation of antibodies |
| 05/31/2007 | WO2007025219A3 Nogo receptor polypeptides and polypeptide fragments and uses thereof |
| 05/31/2007 | WO2007024947A3 Canine influenza vaccines |
| 05/31/2007 | WO2007019549A3 Composition and method for use in cartilage affecting conditions |
| 05/31/2007 | WO2007007145A3 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 05/31/2007 | WO2007006041A3 Imaging and therapeutic method using monocytes |
| 05/31/2007 | WO2007005934A3 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 05/31/2007 | WO2007001361A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/31/2007 | WO2007000343A3 Process for manufacturing vaccines |
| 05/31/2007 | WO2007000342A3 Immunogenic composition |
| 05/31/2007 | WO2007000341A3 Immunogenic composition |
| 05/31/2007 | WO2007000314A3 Immunogenic composition |
| 05/31/2007 | WO2006131936B1 Hepatitis c virus vaccine |
| 05/31/2007 | WO2006127900A3 Tl1a in the treatment of disease |
| 05/31/2007 | WO2006122046A3 Vascular disease therapies |
| 05/31/2007 | WO2006118772A3 Fcrn antibodies and uses thereof |
| 05/31/2007 | WO2006113483A3 Methods and compositions for treating or preventing cancer |
| 05/31/2007 | WO2006113214A3 Vaccine against pandemic strains of influenza viruses |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | WO2006109188A3 Composition for treating cancer adapted for intra-tumoral asministration and uses thereof |
| 05/31/2007 | WO2006102098A3 Immunogens for vaccines against antigenically variable pathogens and diseases |
| 05/31/2007 | WO2006098987A3 Methods of inhibiting angiogenesis and tumor development |
| 05/31/2007 | WO2006096656A3 Methods of applying ionization radiation for therapy of hiv infection |
| 05/31/2007 | WO2006078294A3 Alphavirus vectors for respiratory pathogen vaccines |
| 05/31/2007 | WO2006076383A3 Composition and method for inducing a protective vaccine response |
| 05/31/2007 | WO2006039707A3 Domain ii mutants of anthrax lethal factor |
| 05/31/2007 | WO2006004593A3 Method for preventing and treating mast cell mediated diseases |
| 05/31/2007 | WO2005117970A3 Antibodies of angiogenesis inhibiting domains of cd148 |
| 05/31/2007 | WO2005094338A3 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 05/31/2007 | WO2005048918A3 Anthrax vaccine |
| 05/31/2007 | WO2004100882A3 Inhibition of drug binding to serum albumin |
| 05/31/2007 | US20070124830 Plastid genetic engineering via somatic embryogenesis |
| 05/31/2007 | US20070123524 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS |